AACR Annual Meeting 2017: Immunotherapy Provides Long-lasting Responses to Certain Cancer Types – CANCER RESEARCH Catalyst

Now that a plethora of clinical trials have established positive responses from immunotherapies—immune checkpoint inhibitors, in particular—in patients with a variety of cancer types, one of the logical next questions is, are the responses durable?

Source: AACR Annual Meeting 2017: Immunotherapy Provides Long-lasting Responses to Certain Cancer Types – CANCER RESEARCH Catalyst

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s